Pharmacy
NACDS lauds CMS letter challenging PBM and health plan tactics
NACDS is welcoming a proactive move by the Centers for Medicare & Medicaid Services (CMS) to outline increasing concerns about certain practices by some plans and pharmacy benefit managers (PBMs) that “threaten the sustainability of many pharmacies, impede access to care, and put increased burden on
Dr. Reddy’s debuts on the Dow Jones Sustainability World Index
HYDERABAD, India – Dr. Reddy’s Laboratories has won back-to-back global recognitions for its commitment and progress on sustainability and Environment Social and Governance (ESG) agenda. Dr.
PQA appoints 2024 board of directors and executive committee
ALEXANDRIA, Va. – The Pharmacy Quality Alliance (PQA) Board of Directors appointed seven new members to the 25-member board and approved its 2024 Executive Committee during the 2023 fourth quarter meeting. Individuals will begin serving January 1.
Crystal Lennartz named president of Health Mart and Health Mart Atlas
McKesson has appointed Crystal Lennartz as president of Health Mart, an independent pharmacy franchise, and Health Mart Atlas, a pharmacy services administrative organization (PSAO).
PCMA issues statement on House vote of H.R. 5378
The Pharmaceutical Care Management Association (PCMA) released the following statement on the U.S. House of Representatives’ vote on the Lower Costs, More Transparency Act. “America’s pharmacy benefit companies are extremely disappointed by the passage of H.R. 5378 by the U.S.
HDA issues statement on CNBC special report on Rx counterfeiting
Healthcare Distribution Alliance (HDA) president and CEO Chester “Chip” Davis, Jr., released the following statement in response to CNBC’s reporting on counterfeit medications and the role of pharmaceutical distributors.
NACDS praises House passage of bipartisan bill to help deliver essential PBM reforms in Medicaid
NACDS is applauding the passage of the Lower Costs, More Transparency Act (H.R. 5378) by the U.S. House of Representatives today. The bill — which was introduced by U.S. Representative Cathy McMorris Rodgers (R-WA) on September 8 — is a vital aspect of pharmacy benefit manager (PBM) reform.
NCPA urges House passage of PBM reform package
ALEXANDRIA, Va. – The National Community Pharmacists Association issued the following statement from Anne Cassity, senior vice president of government affairs, as the House of Representatives prepares to vote today on the Lower Costs, More Transparency Act (H.R.
The shifting profit pie: How earnings across the pharma sector are changing
How is the pharmaceutical value chain faring financially? Who are the biggest winners and losers? Every two years, Kearney analyzes pharmaceutical profit pools to answer those questions. Our analysis follows a drug across the value chain, from concept to patient.
Dr. Reddy’s Balasubramanian on growth engines
Dinakaran (Dina) Balasubramanian, head of commercial strategy and insights for biologics at Dr. Reddy’s Laboratories, spoke with Chain Drug Review about his role at the drug maker and how specialty generic drugs and biosimilars are fueling growth for it.
Kroger and Soda Health collaborate to launch a Smart Benefits program
CINCINNATI – Kroger Health, the healthcare division of The Kroger Co., and Soda Health, Inc. announced the launch of a Smart Benefits program, which combines Kroger Health’s services with Soda Health’s &more platform.
Americans’ access to Rx services, NACDS defines 2023 vctories and 2024 needs
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) is hailing collaborative advocacy and policymaking that made further strides for Americans’ health care access in 2023.
Kinney Drugs celebrating National Influenza Vaccination Week
GOUVERNEUR, N.Y. – Kinney Drugs is encouraging its customers, especially during National Influenza Vaccination Week (December 4-8), to schedule their flu shots in advance of the holiday season and the new year celebrations.
AllianceRx Walgreens Pharmacy selected to distribute XDEMVY
DEERFIELD, Ill. – AllianceRx Walgreens Pharmacy one of the largest specialty and home delivery pharmacies in the U.S. and a subsidiary of Walgreens, is one of four specialty pharmacies selected to distribute XDEMVY® (lotilaner ophthalmic solution) 0.25%.
OneroRx expands with acquisition of three specialty pharmacies
Local Health Specialty, Inc, a subsidiary of OneroRx Inc., announced today that it has completed an acquisition of three pharmacies in Missouri and Indiana. This step is part of OneroRx’s wider focus of expanding their footprint to a regional level.